Simon Dumesnil, Director of Pasithea Therapeutics KTTA, has filed 1 purchase and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $25K. The latest trade was on 05/01.

SD

SD

Simon Dumesnil

Director

Company

Pasithea Therapeutics KTTA

First filing

24/03/01

Trades

5 trades

Buys / sales

1 / 0

12-month net buying

$25K

Last trade

05/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Pasithea TherapeuticsKTTA	Open-market buy	25/11/28	25/12/01	33,333 sh	$0.75	$24,999.75	+1333.3%